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Synthesis of Biocytin-tRNA Suppressor 
 
1. Synthesis of NVOC-Biocytin Cyanomethyl Ester 
 
Biocytin (100 mg, 0.26 mmol, Molecular Probes) and sodium carbonate (56 mg, 0.54 
mmol) were dissolved in a mixture of water (15 ml) and THF (10 ml).  A solution of 6-
nitroveratryloxycarbonyl chloride (NVOC-Cl) (74 mg, 0.26 mmol, Sigma) in 10 ml THF was 
added slowly.  After 3 hours, solvents were removed in vacuo.  Then, 3 ml of dry DMF and 3 ml 
of chloroacetonitrile, as well as 800 µl triethylamine was added into remaining residues.  After 
overnight stirring, solvents were removed in vacuo and the remaining solid was purified by flash 
chromatography (silica gel, 10% MeOH in CH2Cl2). 
 
2. Preparation of Biocytin-dpCpA 
 
Tetrabutylammonium salt of dinucleotide (dpCpA) was a gift from Prof. Dennis 
Dougherty’s group (Division of Chemistry and Chemical Engineering, California Institute of 
Technology).  At room temperature, 10 mg dpCpA (8.3 µmol) and 16 mg NVOC-biocytin 
cyanomethyl ester (25 µmol) was mixed in dry DMF under argon.  20 µl ammonium acetate (25 
mM, pH 4.5) was added to quench the reaction after 1 hour stirring.  The crude product was 
purified by reversed phase semi-preparative HPLC using a gradient from 25 mM NH4OAc (pH 
4.5) to CH3CN.  The appropriate fractions were combined and lyophilized.  The resulting solid 
was redissolved in 10 mM acetic acid/CH3CN and lyophilized to give 3 mg biocytin-dpCpA as a 
pale yellow solid.  The product was confirmed by mass spectrum as it gives a peak ([M+H]+) at 
MW=1230.4. 
 
3. In vitro Transcription of tRNA 
 
THG73 tRNA was synthesized in vitro from FokI linearized plasmid harboring THG73 
tRNA gene (gift from Prof. Dennis Dougherty’s group) using T7 MEGAshortscript kit (Ambion).  
The product was purified by polyacrylamide gel electrophoresis and dissolved in water. 
 
4. Ligation of Biocytin to THG73 tRNA 
 
The mixture of THG73 tRNA (25 µg in 10 µl water) and HEPES (20 µl, 10 mM, pH 7.5) 
was heated at 94 ºC for 3 minutes and cooled down to 37 ºC slowly.  8 µl biocytin-dpCpA (3 mM 
in DMSO), 32 µl 2.5X reaction buffer (25 µl 400 mM pH 7.5 HEPES; 10 µl 100 mM DTT; 25 µl 
200 mM MgCl2; 3.75 µl 10 mM ATP; 10 µl 5 mg/ml BSA; 26.25 µl water; 1 µl RNasin 
(Promega)), 5 µl water, as well as 5 µl T4 RNA ligase (New England Biolabs) was added.  After 
1 hour incubation at 37 ºC, the reaction mixture was extracted once with an equal volume of 
phenol (saturated with 300 mM sodium acetate, pH 5.0):CHCl3:isoamyl alcohol (25:24:1), then 
precipitated with 3 volume of cold ethanol at -20 ºC.  The precipitate was washed with cold 70% 
(v/v) ethanol, dried under vacumm, and resuspended in 5 µl 1mM sodium acetate, pH 5.0.  The 
amount of biocytin-tRNA was quantified by measuring A260 and the concentration was adjusted 
to 1 µg/µl with 1 mM sodium acetate (pH 5.0).  Prior to the suppression reaction, the biocytin-
tRNA solution was deprotected by xenon lamp equipped with a 315 nm cut-off filter for 5 
minutes.  
  
General procedure to make mRNA-peptide fusions 
 
1. Construction of Fusion Template 
 
Synthetic DNA templates including Pep1 (5’-ACTATTTACAACCACCATGGGCCGCC 
AGGAGATCCACTGGGCCAACGACCTGTGCAAGCCCTTCTGGGTGTACACCTCC-3’), 
Pep2 (5’-ACTATTTACAACCACCATGGGCTAGCTTGACTACAAGGACGAGGACAAGCG 
CCAGGAGATCCACTTGGCCAACGACCTGTGCAAGCCCTTCTGGGTGTACACCTCC-3’), 
Lib1 (5’-ACTATTTACAACCACCATGGGCCGCCAGGAGATCCACNNSGCCAACGACCTG 
TGCAAGCCCTTCTGGGTGTACACCTCC-3’) were purified by preparative polyacrylamide gel 
electrophoresis.  Polymerase chain reaction (PCR) of these templates with two synthetic primers, 
sd2 (5’-GGATTCTAATACGACTCACTATAGGGACAATTACTATTTACAACCACCATG-3’) 
and sd26 (5’-GCCGCCGCCGCCGGAGGTGTACACCCAGAAG-3’), generates double stranded 
DNA.  mRNA was produced by T7 runoff transcription of these templates in the presence of 
RNAsecure (Ambion) followed by size exclusion column purification (NAP25 column,  
Amersham Pharmacia Biotech).  The flexible DNA linker containing puromycin, F30P (5’-
dA21[C9]3dACdCP; C9=triethylene glycol phosphate, Glen Research; P = CPG-puromycin, Glen 
Research), was synthesized using standard chemistry.  The oligonucleotide was chemically 
phosphorylated using phosphorylation reagent II (Glen Research) and purified by OPC cartridge.  
Ligation of pF30P to transcribed mRNA was done by mixing mRNA, pF30P,  a splint (5’-
TTTTTTTTTTTTGCCGCCGCCGCC-3’) in a 1:0.5:1.2 ratio with 2 Units of T4 DNA ligase 
(New England Biolabs) per picomole of template mRNA.  After ligation, the fusion template was 
gel-purified, electroeluted and desalted by ethanol precipitation. 
 
2. Translation and Fusion Formation 
 
The fusion template was translated in reticulocyte lysate (Novagen) using standard 
conditions (800 nM template) with the addition of 35S-methionine as the labeling reagent.  In the 
case of templates containing UAG stop codon, 2 µg of deprotected biocytin-tRNA suppressor 
was also added.  On completion of translation, fusion formation was stimulated by addition of 
MgCl2 and KCl to 50 mM and 0.6 M, respectively, and incubated at -20 ºC overnight.  The 
resulting 35S-labeled mRNA peptide fusions were directly loaded to 15% tricine SDS-PAGE for 
separation.  After running, the gel was dried and exposed to phosphor screen (Molecular 
Dynamics) for several hours.  The phosphor screen was then scanned to give image shown on 
Figure 2B. 
 
Enrichment of UAG Stop Codon by Selection against Streptavidin-Agarose Matrix 
 
1. Template-base (dT) Purification 
 
To isolate fusion, the lysate was diluted in binding buffer (1M NaCl, 20 mM Tris pH 8.0, 
1 mM DTT, 10 mM EDTA, 0.2% Trition X-100) and incubated with dT-cellulose at 4 ºC for 1 
hour.  Bound fusions were washed with washing buffer (0.3M NaCl, 20 mM Tris pH 8.0) and 
eluted by ddH2O. 
 
2. Reverse Transcription and Selective Step 
 
Fusion after dT purification was concentrated and used for reverse transcription with 
Superscript II RNase H- reverse transcriptase (BRL, life Technologies) following standard 
conditions recommended by the manufacturer.  The reaction mixture (50 µl) was directly added 
into 1 ml phosphate buffer (50 mM, pH 7) and streptavidin-agarose matrix (Pierce).  After a 1- 
hour incubation at 4 ºC, the matrix was washed with washing buffer (50 mM phosphate pH 8.0, 
100 mM NaCl, 0.1% SDS) 500 µl × 6 times.  The matrix then was used for PCR amplification 
with sd2 and sd26.  The PCR product was cloned with TOPO Clone kit (Invitrogen) for 
sequencing. 
 
 
